VITAMINSHOPPE COM INC
SC 13D/A, EX-6, 2001-01-17
CATALOG & MAIL-ORDER HOUSES
Previous: VITAMINSHOPPE COM INC, SC 13D/A, EX-5, 2001-01-17
Next: AGILENT TECHNOLOGIES INC, 10-K, 2001-01-17




                                                                       Exhibit 6

Commitment for Private Equity Financing



                                VS INVESTORS LLC
                                 299 Park Avenue
                               New York, NY 10171

                                January 12, 2001


Vitamin Shoppe Industries Inc.
4700 Westside Avenue
North Bergen, New Jersey 07047

         Re:      Commitment for Private Equity Financing
                  ---------------------------------------

Ladies and Gentlemen:

         You have advised us that Vitamin Shoppe Industries Inc. (the "Company")
is seeking private equity financing (the "Private Equity  Financing") to finance
the  acquisition of all of the issued and  outstanding  shares of Class A common
stock of  VitaminShoppe.com,  Inc., a Delaware  corporation (the  "Subsidiary"),
pursuant to a merger of the Subsidiary with and into the Company (the "Merger"),
with the Company being the surviving corporation.

         Based upon and  subject to the terms and  conditions  set forth in this
Commitment Letter (the "Commitment  Letter"),  VS Investors LLC (the "Investor")
hereby commits to purchase, through one or more affiliated entities or nominees,
at a  valuation  previously  agreed to by the Company  and the  Investor,  newly
issued  shares of common stock and/or  preferred  stock of the Company (the "New
Stock"),   in  an  amount   sufficient   for  the  Company  to  pay  the  merger
consideration,  which is approximately  $7.3 million,  and the transaction costs
related thereto,  up to a maximum  commitment of $10 million (the  "Commitment",
and together with the Private Equity Financing and the Merger, the "Contemplated
Transactions").  The Investor acknowledges that each of the current shareholders
and warrant  holders of the Company may elect to purchase  its pro rata share of
the New Stock  offered by the  Company in  connection  with the  Private  Equity
Financing.

         The Company and Investor shall execute definitive documentation related
to the Private Equity Financing, including a stock purchase agreement containing
standard  and  customary  terms,   representations,   warranties  and  covenants
(collectively,  the "Definitive  Documents").  The commitments and agreements of
the  Investor  hereunder  shall  are  subject  only to (i) the  approval  of the
Company's  lenders and (ii) the condition  that the  consummation  of the Merger
occur simultaneously with, or substantially  simultaneously with, the closing of
the Private Equity Financing.

         Except as required by applicable law,  including in connection with any
documents  required to be filed with the Securities  and Exchange  Commission or
provided to the  Subsidiary's  shareholders in connection with the  Contemplated
Transactions,  this  Commitment  Letter  and  the  contents  of  any  Definitive
Documents  shall not be disclosed by the Company to any third party  without the
prior consent of the Investor, other than to the Company's attorneys,



<PAGE>



Vitamin Shoppe Industries Inc.
January 12, 2001
Page 2



financial advisors and accountants, but in each case only in connection with the
Contemplated Transactions.

         The provisions of the immediately  preceding  paragraph shall remain in
full  force and  effect  regardless  of whether  Definitive  Documents  shall be
executed and delivered and  notwithstanding  the  termination of this Commitment
Letter;  provided,  however,  that if any Definitive  Documents are executed and
delivered,  to the extent the provisions  contained therein specifically address
any issue  provided for in the  provisions of any of the  immediately  preceding
paragraph,  the applicable  terms of such  Definitive  Documents shall supercede
such provisions of the immediately preceding paragraph.

         This Commitment  Letter may be executed in counterparts,  each of which
shall constitute an original but all of which, taken together,  shall constitute
a single  agreement.  This Commitment  Letter embodies the entire  agreement and
understanding  between the Company and the Investor with respect to the specific
matters set forth herein and supersedes all prior agreements and  understandings
relating to the subject matter hereof.

         THIS COMMITMENT LETTER SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE
WITH THE LAWS OF THE STATE OF NEW  YORK,  WITHOUT  REGARD TO ANY  JURISDICTION'S
PRINCIPLES OF CONFLICTS OF LAW.

         If you are in agreement with the  foregoing,  please  countersign  this
Commitment  Letter where  indicated  below and return it, by fax and first class
mail,  to us at  the  fax  number  and  address  indicated  at the  top of  this
Commitment Letter.  Following acceptance by the Company,  this Commitment Letter
shall expire at 5:00 p.m. on April 10, 2001 unless the Private Equity  Financing
is closed by such time.


                            [Signature page follows.]



<PAGE>



Vitamin Shoppe Industries Inc.
January 12, 2001
Page 3



                                  Very truly yours,

                                  VS INVESTORS LLC

                                  By: FdG Associates Acquisition L.P., the Class
                                      C Member

                                      By: FdG Acquisition Corp., its General
                                          Partner

                                           By: /s/ M. Anthony Fisher
                                           -----------------------
                                           Name:  M. Anthony Fisher
                                           Title: Vice President




ACCEPTED AND AGREED TO THIS
12TH DAY OF JANUARY, 2001:

VITAMIN SHOPPE INDUSTRIES INC.


By:      /s/ Jeffrey J. Horowitz
         -----------------------
Name:    Jeffrey J. Horowitz
         ----------------------
Title:   Chairman
         ----------------------







© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission